applied to the production of therapeutic proteins has several disadvantages: ligand leakage
72 hours) against Ba/F3-TPM3-NTRK1
InChi: InChI=1S/C58H90N12O16/c1-7-11-13-20-35(73)28-38-48(76)57(85)62-37(23-24-44(59)74)49(77)60-29-45(75)69-25-16-21-42(69)54(82)64-39(27-34-18-14-12-15-19-34)51(79)67-46(32(5)8-2)56(84)66-40(30-71)52(80)61-36(10-4)50(78)65-41(31-72)53(81)68-47(33(6)9-3)58(86)70-26-17-22-43(70)55(83)63-38/h10
Smiles: [2H]C1C2=CC=CC=C2N(C(N)=O)C2=CC=CC=C2C=1[2H]
Smiles: CCCCCCCCCCCCCCCCCCCC(O)=O
Etifoxine-d5 - CAS# 1346598-10-4 Catalog No.:M35009-C applied to the production ofEtifoxine d5 is the deuterium labeled Etifoxine. Etifoxine, a non benzodiazepine GABAergic compound, is a positive allosteric modulator of 122 and 132 subunit containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents. Product information CAS Number: 1346598 10 4 Molecular Weight: 305. 81 Formula: C17H17ClN2O Chemical Name: 6 chloro N ethyl 4 methyl 4 [(2,3,4,5,6 H)phenyl] 4H 3,1 benzoxazin 2 amine Smiles: